Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $7.15B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 7.38M
Average 7.51M
OSCR Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Oscar Health, Inc.NYSE: OSCR
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables falls 49.0% from a year ago
Net receivables stood at $380.06M at the end of Q2 FY2026, down 49.0% from a year earlier and down 35.3% from the prior quarter. Over 3 fiscal years it compounded at -27.5% a year.
Context
- Net receivables amounted to 3.4% of total assets at the end of Q2 FY2026, down 8.3 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -49.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 442.65M USD
- Year-over-year change
- +40.1%
- 4-year CAGR
- -19.3%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 442.65M | +40.1% |
| FY2024 | 2024-12-31 | 315.89M | -36.1% |
| FY2023 | 2023-12-31 | 494.39M | -57.4% |
| FY2022 | 2022-12-31 | 1.16B | +11.1% |
| FY2021 | 2021-12-31 | 1.04B | — |
Net Receivables vs competitors
How OSCR compares with its peers on the latest reported figures
- OSCR's Jun 2026 net receivables of $380.06M is the 6th highest of the 8 companies compared; the peer median is $18.08B.
- Its year-over-year change of -49.0% is the lowest of 8, against a peer median of -0.7%.
- Net receivables amounts to 3.4% of total assets for OSCR, versus a peer median of 21.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $40.31B | -0.8% | +13.4% | 15.9% | |
| Sep 2026 | $31.49B | -0.7% | +19.2% | 20.0% | |
| Sep 2026 | $24.57B | +67.7% | +9.1% | 19.2% | |
| Jun 2026 | $18.08B | -16.1% | +10.9% | 21.8% | |
| Sep 2026 | $3.36B | -4.4% | +15.3% | 21.5% | |
| Jun 2026 | $380.06M | -49.0% | -27.5% | 3.4% | |
| Mar 2026 | $277.68M | +29.7% | +39.7% | 22.0% | |
| Jun 2026 | $202.74M | +54.4% | -1.8% | 28.1% | |
| Peer median (excluding OSCR) | $18.08B | -0.7% | +13.4% | 21.5% | |
Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.1B | 1.56B | 1.87B | 1.53B | 2.77B |
| Short-term Investments | 587.09M | 1.4B | 689.83M | 624.46M | 1.22B |
| Net Receivables | 1.04B | 1.16B | 494.39M | 315.89M | 442.65M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 28.09M | 27.48M | (982.95M) | 377.64M | 180.15M |
| Total Current Assets | 2.76B | 4.14B | 2.07B | 2.85B | 4.61B |
| Property, Plant & Equipment (Net) | 46.61M | 59.89M | 61.93M | 66.79M | 88.35M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 844.48M | 222.92M | 365.31M | 1.82B | 1.47B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | (335.44M) | 101.21M | 1.1B | 113.28M | 152.67M |
| Total Non-current Assets | 555.65M | 384.01M | 1.53B | 2B | 1.71B |
| Total Assets | 3.32B | 4.53B | 3.6B | 4.84B | 6.33B |
| Account Payables | 718.81M | 1.37B | 1.03B | 1.4B | (99.75M) |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 75.04M | 79M | 0 | 0 | 0 |
| Other Current Liabilities | 29.25M | 4.21M | (2.26B) | 215.28M | 4.96B |
| Total Current Liabilities | 1.62B | 2.97B | (175.28M) | 3.17B | 4.86B |
| Long-term Debt | 0 | 298M | 298.78M | 299.56M | 430.1M |
| Deferred Tax Liabilities | 4.11M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 311.63M | 370.12M | 2.67B | 61.28M | 51.99M |
| Total Non-current Liabilities | 315.74M | 668.12M | 2.97B | 360.84M | 482.09M |
| Total Liabilities | 1.93B | 3.63B | 2.8B | 3.82B | 5.34B |
| Common Stock | 2K | 2K | 2K | 2K | 3K |
| Retained Earnings | (2B) | (2.61B) | (2.88B) | (2.85B) | (3.29B) |
| Accumulated OCI | (3.67M) | (9.72M) | 1.31M | (1.83M) | 18.03M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.29M | 2.02M | 2.15M | 2.84M | 3.09M |
| Total Equity | 1.39B | 892.4M | 806.12M | 1.02B | 980.74M |
| Total Debt | 0 | 298M | 298.78M | 299.56M | 430.1M |
| Net Debt | (1.1B) | (1.26B) | (1.57B) | (1.23B) | (2.34B) |
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$27.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.